What the FDA labels say about taking them together
Metoclopramide and rivastigmine
Rivastigmine's FDA label of June 19, 2024 names metoclopramide in its drug interactions section; the metoclopramide labels PlainMeds reads (2) do not name rivastigmine. The rivastigmine label: “DRUG INTERACTIONS Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended”
Check it at the source: the metoclopramide FDA label on DailyMed (effective May 18, 2026, ANI Pharmaceuticals, Inc.); the rivastigmine FDA label on DailyMed (effective June 19, 2024, Aurobindo Pharma Limited).
What does the metoclopramide label say about rivastigmine?
Metoclopramide's label (effective May 18, 2026) and its 1 other brand-application label do not name rivastigmine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Metoclopramide), NDA017854 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective May 18, 2026 (SPL set 797aad80-0597-42f8-99d5-39de180c3b5a), via openFDA; the full label on DailyMed
What does the rivastigmine label say about metoclopramide?
Rivastigmine label, drug interactionsDRUG INTERACTIONS Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended
Source: FDA drug label (Exelon, NDA022083), Sandoz Inc, effective May 8, 2024 (SPL set b6ed6d15-116d-4596-92ce-3414574d7ba0), via openFDA
Source: FDA drug label (Rivastigmine Tartrate), Aurobindo Pharma Limited, effective June 19, 2024 (SPL set c246a0e5-1e77-41ee-a7b3-384f21f2f2e0), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Metoclopramide | Rivastigmine | |
|---|---|---|
| Labeled for | Acid reflux and ulcers, Nausea and vomiting | Alzheimer's disease |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $0.0439 per tablet 10 mg tablet | $0.164 per capsule 1.5 mg capsule |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once